Literature DB >> 11323577

Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.

G D De Palma1, G Galloro, S Siciliano, P Iovino, C Catanzano.   

Abstract

BACKGROUND: The necessity for drainage of both liver lobes in tumors arising at the biliary bifurcation is controversial. The aim of this study was to compare the outcome of unilateral versus bilateral drainage in patients with biliary obstruction at the hilum.
METHODS: One hundred fifty-seven consecutive patients with primary cholangiocarcinoma, gallbladder cancer, or periportal lymph node metastases were randomly allocated to unilateral (group A) or bilateral (group B) hepatic duct drainage.
RESULTS: In intention-to treat analysis, group A had a significantly higher rate of successful endoscopic stent insertion than group B (88.6% vs. 76.9%, p = 0.041). Group B had a significantly higher rate of complications than group A (26.9% vs. 18.9%, p = 0.026) because of the higher rate of early cholangitis (16.6% vs. 8.8%, p = 0.013). In per-protocol analysis the rate of successful drainage, complications, and mortality did not differ between the two groups. Median survival did not differ between the two groups but was significantly different for patients with cholangiocarcinoma and those with gallbladder cancer versus patients with metastatic tumors (p = 0.0247).
CONCLUSION: The insertion of more than one stent would not appear justified as a routine procedure in patients with biliary bifurcation tumors.

Entities:  

Mesh:

Year:  2001        PMID: 11323577     DOI: 10.1067/mge.2001.113381

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  101 in total

1.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Endoscopic Therapy for Inflammatory Bowel Disease.

Authors:  Eric S. Goldstein; Peter H. Rubin
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

3.  Side-by-side versus stent-in-stent deployment in bilateral endoscopic metal stenting for malignant hilar biliary obstruction.

Authors:  Itaru Naitoh; Kazuki Hayashi; Takahiro Nakazawa; Fumihiro Okumura; Katsuyuki Miyabe; Shuya Shimizu; Michihiro Yoshida; Hiroaki Yamashita; Hirotaka Ohara; Takashi Joh
Journal:  Dig Dis Sci       Date:  2012-06-26       Impact factor: 3.199

4.  Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients.

Authors:  Jennifer Hsieh; Amar Thosani; Matthew Grunwald; Satish Nagula; Juan Carlos Bucobo; Jonathan M Buscaglia
Journal:  Hepatobiliary Surg Nutr       Date:  2015-10       Impact factor: 7.293

Review 5.  Current status of endoscopic biliary drainage for unresectable malignant hilar biliary strictures.

Authors:  Hironari Kato; Koichiro Tsutsumi; Hirofumi Kawamoto; Hiroyuki Okada
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

6.  Cholangiocarcinoma.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

7.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 8.  Hilar strictures - clear management strategies start to emerge.

Authors:  Robert Enns
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

9.  Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome.

Authors:  S D Mansfield; O Barakat; R M Charnley; B C Jaques; C B O'Suilleabhain; P J Atherton; D Manas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 10.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.